Literature DB >> 27068269

Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.

Kaifeng Guo1, Lei Zhang1, Fangya Zhao1, Junxi Lu1, Pan Pan1, Haoyong Yu1, Yuqian Bao1, Haibing Chen2, Weiping Jia3.   

Abstract

AIMS: This cross-sectional study aimed to determine the prevalence and associated risk factors of chronic kidney disease (CKD) in Chinese type 2 diabetic patients.
METHODS: A total of 3301 patients with type 2 diabetes were included in this study. Anthropometric parameters and biochemical indices were measured. The main outcome measures were detection of CKD, albuminuria and estimated glomerular filtration rate (eGFR).
RESULTS: The prevalence of CKD and albuminuria in Shanghai Chinese type 2 diabetic patients was 27.1% and 25.2%. The prevalence of mildly decreased renal function or worse (eGFR<60/mL/min/1.73m(2)) was 6%. The prevalence of glomerular hyperfiltration was 12.2%. The prevalence of diabetic kidney disease (DKD) according to the newest NKF's KDOQI classification was 12.03%. Risk factors associated with DKD were SBP, retinopathy, neuropathy, TG, LDL, anemia and HbA1c. Clinical factors associated with both albuminuria and low eGFR (≥60/<60) were SBP, retinopathy, TC, TG and anemia.
CONCLUSION: In conclusion, CKD and DKD were common in the Shanghai Chinese patients with T2DM and were similar to that in Western patients. Prevention and control of diabetes should be a high priority in reducing the CKD burden in China.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albuminuria; Chronic kidney disease; Diabetic kidney disease; Hyperfiltration; Prevalence; Type 2 diabetes

Mesh:

Year:  2016        PMID: 27068269     DOI: 10.1016/j.jdiacomp.2016.03.020

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  22 in total

Review 1.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

2.  Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual-acting glucokinase activator.

Authors:  Jia Miao; Ping Fu; Shuang Ren; Chao Hu; Ying Wang; Chengfeng Jiao; Ping Li; Yu Zhao; Cui Tang; Yuli Qian; Rong Yang; Yanli Dong; Jing Rong; Yaohui Wang; Xiaowei Jin; Yu Sun; Li Chen
Journal:  Clin Transl Sci       Date:  2021-11-11       Impact factor: 4.689

3.  The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care.

Authors:  Lingwang An; Qiuzhi Yu; Hong Tang; Xianglan Li; Dandan Wang; Qi Tang; Haiyang Xing; Yali He; Xiaona Zhao; Shuhui Zhao; Yaujiunn Lee; Juming Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

4.  Ocular findings, surgery details and outcomes in proliferative diabetic retinopathy patients with chronic kidney disease.

Authors:  Jipeng Li; Aman Chandra; Lin Liu; Lin Zhang; Jun Xu; Meng Zhao
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

5.  Protective effect of tartary buckwheat on renal function in type 2 diabetics: a randomized controlled trial.

Authors:  Ju Qiu; Zaigui Li; Yuchang Qin; Yanfen Yue; Yanping Liu
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

6.  Association of Chronic Kidney Disease with Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus: An Observational Cross-sectional Study in Hangzhou, China.

Authors:  Xue Sun; Jie He; Xiao-Li Ji; Yi-Ming Zhao; Han-Yu Lou; Xiao-Xiao Song; Li-Zhen Shan; Ying-Xiu Kang; Wen-Heng Zeng; Xiao-Hong Pang; Song-Zhao Zhang; Yue Ding; Yue-Zhong Ren; Peng-Fei Shan
Journal:  Chin Med J (Engl)       Date:  2017 5th Jan 2017       Impact factor: 2.628

7.  Glycated Hemoglobin is Independently Associated with Albuminuria in Young Nondiabetic People with Obesity: A Cross-Sectional Study.

Authors:  Yanli Li; Juan Shi; Xiaolin Huang; Rui Wang; Bin Gu; Peiwen Liang; Shaoqian Zhao; Yingkai Sun; Wen Liu; Yuying Deng; Liuqing Xi; Dandan Zhao; Dalong Song; Yanan Cao; Yifei Zhang; Weiqiong Gu; Jie Hong
Journal:  Med Sci Monit       Date:  2017-05-29

8.  Microribonucleic acid-192 as a specific biomarker for the early diagnosis of diabetic kidney disease.

Authors:  Xinyi Yang; Shuaihui Liu; Rui Zhang; Bei Sun; Saijun Zhou; Rui Chen; Pei Yu
Journal:  J Diabetes Investig       Date:  2017-09-22       Impact factor: 4.232

9.  Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy.

Authors:  Yun-Peng Chang; Bei Sun; Zhe Han; Fei Han; Shao-Lan Hu; Xiao-Yu Li; Mei Xue; Yang Yang; Li Chen; Chun-Jun Li; Li-Ming Chen
Journal:  Front Pharmacol       Date:  2017-11-01       Impact factor: 5.810

10.  Risk factors of chronic kidney diseases in Chinese adults with type 2 diabetes.

Authors:  Lin Yang; Tsun Kit Chu; Jinxiao Lian; Cheuk Wai Lo; Pak Ki Lau; Hairong Nan; Jun Liang
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.